Protein Assays for Clinical Studies

Clinical research starts with testing for safety and expands further to determine if the treatment is effective. Our protein profiling offerings can support Phase I, Phase II and Phase III clinical trials with monitoring pharmacokinetic (PK) and pharmacodynamic (PD) markers.

Analyses performed under GCP conditions

Simoa and Luminex profiling studies can be conducted under GCP conditions, RPPA can be offered under GCP-like conditions. We have been successfully audited by two top10 pharma companies and one top5 clinical CRO.

Ultra-Sensitive Protein Profiling
We design, establish and validate miniaturized protein assays
High-throughput protein profiling

We serve all stages of drug development

We offer protein profiling services for different stages of drug development. The services vary from high-content protein profiling, high-throughput protein profiling, ultra-sensitive protein profiling, etc. For protein profiling in clinical studies, we offer services under GCP-like conditions.

Other applications

Protein profiling approaches for protein biomarker discovery
Protein profiling approaches for protein biomarker screening
Compound mechanism/mode of action studies: protein profiling methods.
Protein profiling methods for safety and toxicology
Protein profiling techniques for in-vivo pharmacology studies
Development of immuno-assays tailored to our customer's needs - fully customizable.

Feel free to contact us at any point. We can help you find the right services for your needs.

 

Back to top